Jim Simons started to build up the position in Windtree Therapeutics in Q1 2021 and continued to invest until Q2 2022. Since then they sold 14.5 Thousand shares. The investor completely sold their stake between Q3 2022 and Q1 2023.
Avg closing price
Price range
Sold -6.71 Thousand shares
Q1 2023
Avg closing price
$7.44
Price range
$4.41
-
$12.50
Sold 46.1% shares (-5.75 Thousand shares)
Q4 2022
Avg closing price
$9.88
Price range
$7.95
-
$15.65
Sold 13.8% shares (-1.99 Thousand shares)
Q3 2022
Avg closing price
$19.87
Price range
$14.94
-
$35.00
Increased shares by 54.2% (+5.08 Thousand shares)
Q2 2022
Avg closing price
$32.78
Price range
$19.13
-
$57.00
Increased shares by 8.8% (+757 shares)
Q1 2022
Avg closing price
$58.36
Price range
$47.02
-
$80.00
Increased shares by 15.0% (+1.12 Thousand shares)
Q4 2021
Avg closing price
$88.97
Price range
$70.00
-
$115.50
Increased shares by 28.6% (+1.67 Thousand shares)
Q3 2021
Avg closing price
$94.65
Price range
$83.00
-
$113.50
Increased shares by 1156.0% (+5.36 Thousand shares)
Q2 2021